AMRX: Amneal Pharmaceuticals Inc - Class A
AMRX exchange rate has changed by -2.41% for today. During the day, the instrument was traded at a low of 17.38 and at a high of 17.71.
Follow Amneal Pharmaceuticals Inc - Class A dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
AMRX News
- AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study
- BHVN Stock Soars 18% on $795M Out-Licensing Deal for Epilepsy Program
- JAZZ Secures FDA Nod for Expanded Use of Ziihera in Gastric Cancer
- SYRE Stock Sinks After Mixed SKYWAY Study Data in Rheumatoid Arthritis
- RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy
- Here's Why You Should Add ACET Stock to Your Portfolio Now
- Acadia Gets European Commission Nod for Daybu in Rett Syndrome
- Are Medical Stocks Lagging Bioventus (BVS) This Year?
- Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?
- TEVA's Ecopipam Wins FDA Priority Tag in Pediatric Tourette Syndrome
- Reasons Why Investors Should Consider Betting on PGEN Stock
- RARE Stock Gains on FDA Nod for Rare Disease Gene Therapy Genglycos
- 4 Healthcare Stocks to Safeguard Your Portfolio as Fed Plans Rate Hike
- AMLX Rises as Avexitide Nears 2026-End Filing With Phase III Study Win
- Nuvectis Stock Surges Around 97% in 3 Months: Here's Why
- Zacks.com featured highlights include CareDx, Healthcare Services, Forum Energy Tech, Amneal Pharma and Caterpillar
- ARGX Announces Positive Phase III Data on Vyvgart Hytrulo, Stock Up
- UTHR Completes Phase III Tyvaso Study Enrollment for Expanded Label
- EYPT Stock Plunges 67% After Duravyu Misses Phase III Eye Disease Goal
- 5 Top-Ranked High-Efficiency Stocks Poised for Stronger Returns
- Nektar Q2 Earnings Beat Estimates, Revenues Lag, Pipeline in Focus
- Kodiak's Q2 Loss Wider Than Expected, Pipeline Development in Focus
- CRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta Gains
- ALT's Q2 Loss Narrower Than Expected, Pemvidutide's Studies in Focus
Frequently Asked Questions
What is AMRX stock price today?
Amneal Pharmaceuticals Inc - Class A stock is priced at 17.44 today. It trades within 17.38 - 17.71, yesterday's close was 17.87, and trading volume reached 2733. The live price chart of AMRX shows these updates.
Does Amneal Pharmaceuticals Inc - Class A stock pay dividends?
Amneal Pharmaceuticals Inc - Class A is currently valued at 17.44. Dividend policy depends on the company, while investors also watch 65.31% and USD. View the chart live to track AMRX movements.
How to buy AMRX stock?
You can buy Amneal Pharmaceuticals Inc - Class A shares at the current price of 17.44. Orders are usually placed near 17.44 or 17.74, while 2733 and -0.74% show market activity. Follow AMRX updates on the live chart today.
How to invest into AMRX stock?
Investing in Amneal Pharmaceuticals Inc - Class A involves considering the yearly range 9.99 - 19.26 and current price 17.44. Many compare -0.74% and 38.96% before placing orders at 17.44 or 17.74. Explore the AMRX price chart live with daily changes.
What are Amneal Pharmaceuticals Inc - Class A stock highest prices?
The highest price of Amneal Pharmaceuticals Inc - Class A in the past year was 19.26. Within 9.99 - 19.26, the stock fluctuated notably, and comparing with 17.87 helps spot resistance levels. Track Amneal Pharmaceuticals Inc - Class A performance using the live chart.
What are Amneal Pharmaceuticals Inc - Class A stock lowest prices?
The lowest price of Amneal Pharmaceuticals Inc - Class A (AMRX) over the year was 9.99. Comparing it with the current 17.44 and 9.99 - 19.26 shows potential long-term entry points. Watch AMRX moves on the chart live for more details.
When did AMRX stock split?
Amneal Pharmaceuticals Inc - Class A has gone through stock splits historically. These changes are visible in , 17.87, and 65.31% after corporate actions.
- Previous Close
- 17.87
- Open
- 17.57
- Bid
- 17.44
- Ask
- 17.74
- Low
- 17.38
- High
- 17.71
- Volume
- 2.733 K
- Daily Change
- -2.41%
- Month Change
- -0.74%
- 6 Months Change
- 38.96%
- Year Change
- 65.31%